AT323719B - Verfahren zur herstellung von neuen n-hydroxyphenylalkyl-beta-(3,4-dihydroxyphenyl)-äthylaminen und deren pharmazeutisch annehmeaben mineralsäureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen n-hydroxyphenylalkyl-beta-(3,4-dihydroxyphenyl)-äthylaminen und deren pharmazeutisch annehmeaben mineralsäureadditionssalzen

Info

Publication number
AT323719B
AT323719B AT318773A AT318773A AT323719B AT 323719 B AT323719 B AT 323719B AT 318773 A AT318773 A AT 318773A AT 318773 A AT318773 A AT 318773A AT 323719 B AT323719 B AT 323719B
Authority
AT
Austria
Prior art keywords
hydroxyphenylalkyl
ethylamines
dihydroxyphenyl
beta
preparation
Prior art date
Application number
AT318773A
Other languages
German (de)
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT323719(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AT323719B publication Critical patent/AT323719B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT318773A 1972-04-12 1973-04-11 Verfahren zur herstellung von neuen n-hydroxyphenylalkyl-beta-(3,4-dihydroxyphenyl)-äthylaminen und deren pharmazeutisch annehmeaben mineralsäureadditionssalzen AT323719B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
AT323719B true AT323719B (de) 1975-07-25

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT318773A AT323719B (de) 1972-04-12 1973-04-11 Verfahren zur herstellung von neuen n-hydroxyphenylalkyl-beta-(3,4-dihydroxyphenyl)-äthylaminen und deren pharmazeutisch annehmeaben mineralsäureadditionssalzen

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)van)
KR (1) KR790000113B1 (en)van)
AR (1) AR203822A1 (en)van)
AT (1) AT323719B (en)van)
AU (1) AU472734B2 (en)van)
BE (1) BE798051A (en)van)
BG (1) BG23001A3 (en)van)
CA (1) CA1018188A (en)van)
CH (2) CH580563A5 (en)van)
CS (2) CS190406B2 (en)van)
CY (1) CY963A (en)van)
DD (1) DD107670B3 (en)van)
DE (1) DE2317710C2 (en)van)
DK (1) DK142750C (en)van)
ES (1) ES413639A1 (en)van)
FR (1) FR2182947B1 (en)van)
GB (1) GB1392674A (en)van)
HK (1) HK50178A (en)van)
HU (2) HU166213B (en)van)
IE (1) IE37511B1 (en)van)
IL (1) IL42016A (en)van)
KE (1) KE2870A (en)van)
MY (1) MY7800381A (en)van)
NL (1) NL174459C (en)van)
PH (1) PH11041A (en)van)
PL (2) PL94207B1 (en)van)
RO (2) RO65105A (en)van)
SE (1) SE399064B (en)van)
SU (1) SU496719A3 (en)van)
YU (2) YU36483B (en)van)
ZA (1) ZA732136B (en)van)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en)van) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
EP0071399A3 (en) * 1981-07-22 1983-12-07 Syntex (U.S.A.) Inc. Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (en)van) * 1989-12-18 1991-08-23
CA2103367A1 (en) * 1991-05-20 1992-11-21 Akihide Koda Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
EP1546088B1 (en) 2002-10-03 2014-12-17 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2560922C (en) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
AU2010278711A1 (en) 2009-07-31 2012-02-23 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (pt) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc composições e métodos para tratar doença neurodegenerativa
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CN110869011B (zh) 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 用于治疗神经退行性疾病的组合物
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
HU166213B (en)van) 1975-02-28
MY7800381A (en) 1978-12-31
NL174459B (nl) 1984-01-16
KE2870A (en) 1978-09-01
IE37511B1 (en) 1977-08-03
IL42016A (en) 1976-05-31
DD107670A5 (de) 1974-08-12
JPS58131945A (ja) 1983-08-06
YU321279A (en) 1983-04-27
SE399064B (sv) 1978-01-30
FR2182947B1 (en)van) 1976-07-02
DK142750C (da) 1981-08-17
AU5438573A (en) 1974-10-17
GB1392674A (en) 1975-04-30
HU167597B (en)van) 1975-11-28
RO70892A (ro) 1982-02-26
AU472734B2 (en) 1976-06-03
PL90695B1 (en)van) 1977-01-31
IL42016A0 (en) 1973-06-29
BE798051A (fr) 1973-10-11
YU36483B (en) 1984-02-29
KR790000113B1 (en) 1979-03-20
JPS497237A (en)van) 1974-01-22
ZA732136B (en) 1974-03-27
CY963A (en) 1978-12-22
YU97673A (en) 1982-02-25
NL7305097A (en)van) 1973-10-16
SU496719A3 (ru) 1975-12-25
DE2317710C2 (de) 1983-08-04
PL94207B1 (en)van) 1977-07-30
ES413639A1 (es) 1976-01-16
CH580563A5 (en)van) 1976-10-15
CA1018188A (en) 1977-09-27
JPS5825656B2 (ja) 1983-05-28
HK50178A (en) 1978-09-15
BG23001A3 (bg) 1977-05-20
PH11041A (en) 1977-10-25
RO65105A (ro) 1980-01-15
CS190448B2 (en) 1979-05-31
DK142750B (da) 1981-01-12
DE2317710A1 (de) 1973-10-18
NL174459C (nl) 1984-06-18
CH569691A5 (en)van) 1975-11-28
DD107670B3 (de) 1988-04-06
FR2182947A1 (en)van) 1973-12-14
CS190406B2 (en) 1979-05-31
AR203822A1 (es) 1975-10-31
YU37113B (en) 1984-08-31
JPS6221343B2 (en)van) 1987-05-12

Similar Documents

Publication Publication Date Title
AT327927B (de) Verfahren zur herstellung von neuen 1,5-benzodiazocinen und deren salzen
ATA266376A (de) Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-phenoxypropanen und von deren saureadditionssalzen
AT323719B (de) Verfahren zur herstellung von neuen n-hydroxyphenylalkyl-beta-(3,4-dihydroxyphenyl)-äthylaminen und deren pharmazeutisch annehmeaben mineralsäureadditionssalzen
AT321276B (de) Verfahren zur Herstellung von neuen substituierten 3-Phenoxy-aminopropan-2-olen und deren Säureadditionssalzen
AT322547B (de) Verfahren zur herstellung von neuen 2-phenylaminoimidazolin-(2)-derivaten und deren säureadditionssalzen
AT319208B (de) Verfahren zur Herstellung von neuen 3-Methylamino-2,4,6,-trijodbenzolverbindungen und deren Salzen
AT326102B (de) Verfahren zur herstellung von neuen 3-amino-2-aminomethyl-2-cyclohexen-1-onen und deren pharmazeutisch verträglichen säureadditionssalzen
AT325018B (de) Verfahren zur herstellung von neuen 1-(trifluormethoxy- oder trifluormethylthiophenyl)-2-aminopropanen und deren säureadditionssalzen
ATA938673A (de) Verfahren zur herstellung von neuen 1-aminomethyl-2,2-diarylcyclopropancarbonsaureamiden und deren saureadditionssalzen und quaternaren salzen
AT320611B (de) Verfahren zur Herstellung von neuen substituierten Phenylformamidinen und deren Säureadditionssalzen
AT313874B (de) Verfahren zur Herstellung von neuen 2-Hydroxy- oder 2,3-Dihydroxy-5-alkoxycarbonyl-benzyloxyaminen und deren Säureadditionssalzen
AT331778B (de) Verfahren zur herstellung von neuen 2,2,3-trimethyl-7-aminonorbornanen und deren saureadditionssalzen
AT324354B (de) Verfahren zur herstellung von neuen n-phenyl-n'-dialkylphosphinylalkylpiperazinen und von deren säureadditionssalzen
AT335417B (de) Verfahren zur herstellung von neuen substituierten 2- (alfa-aminobenzyl) -cycloalkanolen und deren saureadditionssalzen und n-oxyden
AT327907B (de) Verfahren zur herstellung von neuen 1,4-athano-2,3-dihydrochinolinderivaten und deren salzen
ATA195474A (de) Verfahren zur herstellung von neuen 2,4,6-trijod-5-acylaminoisophthalsaureamiden und von deren salzen
AT333763B (de) Verfahren zur herstellung von neuen 1,2,3,4-tetrahydroisochinolinen und deren salzen
ATA202675A (de) Verfahren zur herstellung von neuen 1,2,3,4-tetrahydroisochinolinen und deren salzen
AT327874B (de) Verfahren zur herstellung von 5-hydroxy- oder 5-acetoxy-4,4-diphenyl-2-aminoheptan und deren pharmazeutisch verwendbaren saureadditionssalzen
ATA758275A (de) Verfahren zur herstellung von neuen 2,2,3-trimethyl-7-aminonorbornanen und deren saureadditionssalzen
AT337186B (de) Verfahren zur herstellung von neuen thienodiazepinen sowie deren pharmazeutisch anwendbaren saureadditionssalzen
ATA905575A (de) Verfahren zur herstellung von neuen 2,4,6-trijod-5-acylaminoisophthalsaureamiden und von deren salzen
AT313903B (de) Verfahren zur Herstellung von neuen 1,3-Dihydro-5-aryl-1,4-benzodiazepin-2-onen und von deren Säureadditionssalzen
AT332376B (de) Verfahren zur herstellung von neuen n-(3,3-diphenylpropyl)-propylendiaminen und deren saureadditionssalzen
AT332377B (de) Verfahren zur herstellung von neuen n-(3,3-diphenylpropyl)-propylendiaminen und deren saureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee